Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $20.16M | $19.47M | $170.16M | $33.40M | $38.84M |
| Total Operating Revenue | $20.16M | $19.47M | $170.16M | $33.40M | $38.84M |
| Cost of Revenue | $1.72M | $3.10M | $46.97M | $7.30M | $12.80M |
| Gross Profit | $18.44M | $16.38M | $123.18M | $26.10M | $26.04M |
| Operating Expense | $76.99M | $87.75M | $427.06M | $96.14M | $114.31M |
| Selling and Admin Expenses | $30.78M | $37.83M | $183.29M | $46.01M | $44.95M |
| -General & Admin Expense | $30.78M | $37.83M | $183.29M | $46.01M | $44.95M |
| Research & Development | $46.21M | $49.92M | $243.77M | $50.13M | $69.35M |
| Operating Profit | -$58.55M | -$71.37M | -$303.88M | -$70.05M | -$88.27M |
| Net Non-Operating Interest Income (Expense) | $3.23M | $3.60M | $22.62M | $4.71M | $5.74M |
| Non-Operating Interest Income | $3.23M | $3.60M | $22.62M | $4.71M | $5.74M |
| Other Income (Expense) | -$1.88M | -$8.36M | -$32.34M | -$16.06M | $1.78M |
| Gain on Sale of Security | $1.99M | -$1.21M | -$16.41M | -$18.02M | $3.68M |
| Earnings from Equity Interest | -$4.67M | – | $0.00 | – | – |
| Special Income (Charges) | $0.00 | $0.00 | -$11.40M | $1.14M | -$1.75M |
| -Less:Restructuring and Mergern & Acquisition | $0.00 | $0.00 | $11.40M | $706,000.00 | $1.75M |
| -Less:Write Off | $0.00 | $0.00 | – | – | $0.00 |
| Other Non-Operating Income (Expenses) | $809,000.00 | -$7.15M | -$4.53M | $821,000.00 | -$163,000.00 |
| Pretax Profit | -$57.19M | -$76.14M | -$313.60M | -$81.39M | -$80.75M |
| Tax | $128,000.00 | -$80,000.00 | -$837,000.00 | -$643,000.00 | $1,000.00 |
| Net Profit | -$46.71M | -$82.59M | -$312.76M | -$80.75M | -$80.76M |
| Profit from Continuing Operations | -$57.32M | -$76.06M | -$312.76M | -$80.75M | -$80.76M |
| Net Income from Discontinuous Operations | $10.61M | -$6.53M | – | – | – |
| Net Income to Parent Company | -$46.71M | -$82.59M | -$312.76M | -$80.75M | -$80.76M |
| Net Income to Common Stockholders | -$46.71M | -$82.59M | -$312.76M | -$80.75M | -$80.76M |
| Basic EPS | -$0.75 | -$1.39 | -$5.64 | -$1.42 | -$1.45 |
| Diluted EPS | -$0.75 | -$1.39 | -$5.64 | -$1.42 | -$1.45 |
| Non-Operating Interest Expense | – | – | $0.00 | – | – |
| -Less:Impairment of Capital Assets | – | – | $0.00 | $0.00 | $0.00 |
| -Gain on Sale Of Business | – | – | $0.00 | $0.00 | $0.00 |
| Other Preferred Stock Dividends | – | – | – | – | $0.00 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $990.05M | $1.03B | $1.12B | $1.12B | $1.19B |
| Total Current Assets | $332.54M | $409.96M | $471.84M | $471.84M | $506.08M |
| Cash and Cash Equivalents & Short-Term Investments | $302.16M | $373.46M | $422.62M | $422.62M | $461.86M |
| -Cash and Cash Equivalents | $84.54M | $143.86M | $167.20M | $167.20M | $111.07M |
| -Short Term Investments | $217.63M | $229.59M | $255.42M | $255.42M | $350.80M |
| Receivables | $13.01M | $20.27M | $24.26M | $24.26M | $22.36M |
| -Accounts Receivable | $13.01M | $19.82M | $24.03M | $24.03M | $21.43M |
| -Due from Related Parties Current | $0.00 | $454,000.00 | $229,000.00 | $229,000.00 | $929,000.00 |
| Other Current Assets | $17.36M | $16.23M | $24.96M | $24.96M | $21.86M |
| Total Non-Current Assets | $657.51M | $623.12M | $647.86M | $647.86M | $683.08M |
| Net PPE | $504.85M | $516.82M | $528.70M | $528.70M | $544.79M |
| -Gross PPE | $702.43M | $706.20M | $719.30M | $719.30M | $726.87M |
| -Accumulated Depreciation | -$197.58M | -$189.38M | -$190.60M | -$190.60M | -$182.08M |
| Investments and Advances | $22.27M | $14.60M | $14.88M | $14.88M | $29.89M |
| -Available for Sale Securities | $12.47M | $12.41M | $12.69M | $12.69M | $13.20M |
| -Long Term Equity Investment | $7.62M | – | – | – | – |
| Financial Assets | $119,000.00 | $104,000.00 | $191,000.00 | $191,000.00 | $284,000.00 |
| Goodwill and Other Intangible Assets | $44.39M | $48.86M | $56.92M | $56.92M | $61.52M |
| -Other Intangible Assets | $44.39M | $48.86M | $56.92M | $56.92M | $61.52M |
| Other Non-Current Assets | $85.89M | $42.73M | $47.17M | $47.17M | $46.59M |
| Total Liabilities | $569.76M | $589.92M | $611.11M | $611.11M | $629.38M |
| Total Current Liabilities | $72.74M | $79.60M | $95.97M | $95.97M | $115.28M |
| Payables | $9.58M | $16.31M | $10.57M | $10.57M | $10.70M |
| -Accounts Payable | $9.58M | $16.31M | $10.57M | $10.57M | $10.70M |
| Current Accrued Expenses | $49.95M | $48.38M | $10.50M | $10.50M | $79.34M |
| Current Deferred Liabilities | $13.21M | $14.91M | $19.98M | $19.98M | $25.24M |
| Total Non-Current Liabilities | $497.02M | $510.33M | $515.14M | $515.14M | $514.10M |
| Long Term Debt and Capital Lease Obligation | $404.11M | $410.70M | $417.08M | $417.08M | $422.87M |
| -Long Term Capital Lease Obligation | $404.11M | $410.70M | $417.08M | $417.08M | $422.87M |
| Non-Current Deferred Liabilities | $76.54M | $77.90M | $75.18M | $75.18M | $74.07M |
| Other Non-Current Liabilities | $16.37M | $21.73M | $22.88M | $22.88M | $17.16M |
| Total Equity | $420.28M | $443.15M | $508.59M | $508.59M | $559.78M |
| Stockholders' Equity | $420.28M | $443.15M | $508.59M | $508.59M | $559.78M |
| Capital Stock | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -Common Stock | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $6.70B | $6.67B | $6.66B | $6.66B | $6.63B |
| Retained Earnings | -$6.28B | -$6.23B | -$6.15B | -$6.15B | -$6.07B |
| Gains/Losses Not Affecting Retained Earnings | $950,000.00 | $1.19M | $1.85M | $1.85M | $2.00M |
| Short-Term Debt and Capital Lease Obligation | – | – | $22.81M | $22.81M | – |
| -Current Capital Lease Obligation | – | – | $22.81M | $22.81M | – |
| Other Current Liabilities | – | – | $27.05M | $27.05M | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$44.27M | -$46.69M | -$171.06M | -$47.68M | -$31.61M |
| Net cash flow from continuing operations | -$42.17M | -$46.43M | -$171.06M | -$47.68M | -$42.08M |
| Net Income from Continuing Operations | -$57.32M | -$76.06M | -$312.76M | -$80.75M | -$95.51M |
| Gain/Loss from Continuing Operations | -$1.99M | $1.21M | $16.41M | $16.14M | -$3.68M |
| Depreciation & Depletion & Amortization | $12.32M | $12.80M | $58.99M | $13.66M | $15.26M |
| Other Non-Cash Items | $10.60M | $13.81M | $33.60M | $8.09M | $9.55M |
| Change in Working Capital | -$13.15M | -$14.18M | -$44.09M | -$23.59M | $10.48M |
| -Change in Receivables | $3.71M | -$242,000.00 | -$1.47M | -$1.82M | -$1.85M |
| -Change in Prepaid Assets | -$6.71M | $5.93M | -$5.25M | -$5.18M | $2.97M |
| -Change in Payables and Accrued Expense | $3.94M | -$11.60M | $7.38M | -$9.61M | $20.33M |
| -Change in Other Current Assets | $48,000.00 | $94,000.00 | $4.11M | $334,000.00 | $87,000.00 |
| -Change in Other Current Liabilities | -$11.11M | -$5.75M | -$16.47M | -$2.14M | -$7.85M |
| -Change In Other Working Capital | -$3.03M | -$2.61M | -$32.39M | -$5.18M | -$3.20M |
| Net cash flow from investing | $11.09M | $23.13M | -$240.29M | $95.10M | -$72.82M |
| Net Cash Flow from Continuing Investing Activities | $11.09M | $23.13M | -$240.29M | $95.10M | -$72.82M |
| Net PPE Purchase and Sale | -$2.62M | -$1.93M | -$7.09M | $569,000.00 | $0.00 |
| Net Investment Purchase and Sale | $13.71M | $25.02M | -$233.25M | $94.99M | -$73.07M |
| Net Other Investing Changes | $0.00 | $48,000.00 | $50,000.00 | -$461,000.00 | $249,000.00 |
| Financing Cash Flow | $16.49M | -$19,000.00 | $17.78M | $8.14M | $9.94M |
| Net Cash Flow from Continuing Financing Activities | $16.49M | -$19,000.00 | $17.78M | $8.14M | $9.94M |
| Net Issuance Payments Of Debt | $0.00 | -$19,000.00 | -$354,000.00 | -$25,000.00 | -$24,000.00 |
| Ending Cash Balance | $172.02M | $188.67M | $212.37M | $212.37M | $156.96M |
| Net Change in Cash | -$16.70M | -$23.57M | -$393.57M | $55.56M | -$94.48M |
| Beginning Cash Balance | $188.67M | $212.37M | $605.74M | $156.96M | $251.35M |
| Effect of Exchange Rate Changes | $43,000.00 | -$129,000.00 | $201,000.00 | -$152,000.00 | $93,000.00 |
| Free Cash Flow | -$46.89M | -$48.62M | -$178.72M | -$47.68M | -$31.61M |
| Deferred Tax | – | – | -$1.36M | – | – |
| Net Business Purchase and Sale | – | – | $0.00 | $0.00 | – |
| Net Common Stock Issuance | – | – | $19.47M | $9.15M | – |
| Proceeds from Stock Option Exercised | – | – | $0.00 | $0.00 | – |
| Net Other Financing Charges | – | – | -$1.34M | -$985,000.00 | – |
No comments yet — be the first to weigh in on DNA.